F-18 FDG PET Tests in Malignant Lymphoma
- 8 December 2020
- book chapter
- Published by Springer Nature
- p. 135-147
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Coregistration of Prechemotherapy PET-CT for Planning Pediatric Hodgkin's Disease Radiotherapy Significantly Diminishes Interobserver Variability of Clinical Target Volume DefinitionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 2010Leukemia & Lymphoma, 2010
- Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre‐transplant FDG‐PET scan following salvage chemotherapyBritish Journal of Haematology, 2010
- High SUV uptake on FDG–PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG–PET/CT staging in lymphomaAnnals of Oncology, 2009
- Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of LymphomaJournal of Clinical Oncology, 2009
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2005
- Initial Staging of Lymphoma With Positron Emission Tomography and Computed TomographySeminars in Nuclear Medicine, 2005
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998